FDA.reportPublic FDA data

Application 076898

Type
ANDA
Sponsor
TEVA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CELECOXIBCELECOXIBCAPSULE;ORAL50MGNoNo
002CELECOXIBCELECOXIBCAPSULE;ORAL100MGNoNo
003CELECOXIBCELECOXIBCAPSULE;ORAL200MGNoNo
004CELECOXIBCELECOXIBCAPSULE;ORAL400MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0093-7165CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7165CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7165CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7165CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7165CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7165CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7165CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7165CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7166CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7166CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7166CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7166CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7166CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7166CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7166CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7166CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7170CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7170CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7170CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7170CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7170CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7170CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7170CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7170CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7306CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7306CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7306CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7306CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7306CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7306CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7306CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7306CelecoxibCelecoxibTeva Pharmaceuticals USA, Inc.ANDACurrent
42708-016CelecoxibCelecoxibQPharma IncANDACurrent
42708-016CelecoxibCelecoxibQPharma IncANDACurrent
42708-016CelecoxibCelecoxibQPharma IncANDACurrent
43063-660CelecoxibCelecoxibPD-Rx Pharmaceuticals, Inc.ANDACurrent
50436-3982CelecoxibCelecoxibUnit Dose ServicesANDACurrent
60760-208CelecoxibCelecoxibSt. Mary's Medical Park PharmacyANDACurrent
68084-969CelecoxibCelecoxibAmerican Health PackagingANDACurrent
68084-969CelecoxibCelecoxibAmerican Health PackagingANDACurrent
68084-976CelecoxibCelecoxibAmerican Health PackagingANDACurrent
68084-976CelecoxibCelecoxibAmerican Health PackagingANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
8977ORIG2014-06-02